文献速递皮肤肿瘤

利用美国黑人与白人患者趋势估算黑色素瘤过度诊断

Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.
PubMed 文献 · JAMA Dermatol · 2022-01-01

该队列研究采用Joinpoint回归分析1975至2014年美国监测、流行病学和最终结果(SEER)数据,比较黑人与白人患者的黑色素瘤发病率和死亡率趋势。以黑人患者死亡率趋势作为医疗改善标志,估算白人患者真实癌症发生数,计算过度诊断比例。结果显示2014年白人女性约59%、白人男性约60%的黑色素瘤被过度诊断。

要点

  • 1975至2014年白人女性黑色素瘤发病率增加约4倍(IRR 4.01),白人男性增加约6倍(IRR 5.97)。
  • 同期黑人女性发病率增加不足25%(IRR 1.21),黑人男性增加不足25%(IRR 1.17)。
  • 2014年估计白人女性59%、白人男性60%的黑色素瘤为过度诊断。

核心结论

  • 发病率和死亡率趋势的差异表明美国白人患者中存在相当程度的黑色素瘤过度诊断。

研究设计与样本

  • 队列研究,使用1975至2014年监测、流行病学和最终结果(SEER)数据,采用Joinpoint回归分析黑人与白人患者的黑色素瘤发病率和死亡率趋势,分析按性别分层,数据分析时间为2017年9月至12月。

主要发现

  • 1975至2014年,白人女性黑色素瘤发病率增加约4倍(IRR 4.01 [95% CI, 3.65-4.41]),白人男性增加约6倍(IRR 5.97 [95% CI, 5.47-6.52])。
  • 黑人女性发病率增加不足25%(IRR 1.21 [95% CI, 0.97-1.49]),黑人男性增加不足25%(IRR 1.17 [95% CI, 0.77-1.78])。
  • 黑人女性黑色素瘤死亡率下降约25%(MRR 0.76 [95% CI, 0.63-0.90]),黑人男性下降约25%(MRR 0.72 [95% CI, 0.62-0.84])。
  • 白人女性死亡率稳定(MRR 1.02 [95% CI, 0.96-1.09]),白人男性死亡率增加近50%(MRR 1.49 [95% CI, 1.25-1.77])。
  • 若医疗未改善,估计白人女性死亡率将增加60%,白人男性死亡率将增加一倍以上;基于这些趋势,2014年估计白人女性59%(95% CI, 45%-70%)、白人男性60%(95% CI, 32%-75%)的黑色素瘤为过度诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The incidence of cutaneous melanoma has been rising rapidly among White patients in the US; however, a commensurate increase in mortality due to melanoma has not been observed. These trends suggest overdiagnosis is occurring. OBJECTIVE: To quantify melanoma overdiagnosis among White patients compared with Black patients in the US. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used joinpoint regression of Surveillance, Epidemiology, and End Results data from 1975 to 2014 to determine melanoma incidence and mortality trends among Black and White patients in the US. Using trends in mortality due to melanoma in Black patients as a marker for improvements in medical care, the expected mortality trends in White patients if medical care had not improved were estimated. This served as a marker for the change in true cancer occurrence. Overdiagnosis was calculated as the difference between observed incidence and estimated true cancer occurrence. Analyses were stratified by sex. Data were analyzed from September to December 2017. MAIN OUTCOMES AND MEASURES: Proportion of melanoma cases overdiagnosed among White patients in 2014. RESULTS: From 1975 to 2014, melanoma incidence increased approximately 4-fold in White women (incidence rate ratio [IRR], 4.01 [95% CI, 3.65-4.41]) and 6-fold in White men (IRR, 5.97 [95% CI, 5.47-6.52]), whereas it increased less than 25% in Black women (IRR, 1.21 [95% CI, 0.97-1.49]) and men (IRR, 1.17; [95% CI, 0.77-1.78]). Mortality due to melanoma decreased approximately 25% in Black women (morality rate ratio [MRR], 0.76 [95% CI, 0.63-0.90]) and men (MRR, 0.72 [95% CI, 0.62-0.84]), was stable in White women (MRR, 1.02 [95% CI, 0.96-1.09]), and increased almost 50% in White men (MRR, 1.49 [95% CI, 1.25-1.77]). Had medical care not improved, estimated mortality would have increased 60% in White women and more than doubled in White men. Based on these trends, an estimated 59% (95% CI, 45%-70%) of White women and 60% (95% CI, 32%-75%) of White men with melanoma were overdiagnosed in 2014. CONCLUSIONS AND RELEVANCE: The discrepancies in incidence and mortality trends found in this cohort study suggest considerable overdiagnosis of melanoma occurring among White patients in the US.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Adamson AS, Suarez EA, Welch HG, et al. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US. JAMA Dermatol. 2022. PMID: 35293957. doi:10.1001/jamadermatol.2022.0139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。